We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Allergy Therapeutics Plc | LSE:AGY | London | Ordinary Share | GB00B02LCQ05 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.025 | -0.86% | 2.875 | 2.75 | 3.00 | 3.10 | 2.875 | 2.95 | 759,943 | 11:42:05 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 59.59M | -43.07M | -0.0090 | -3.19 | 136.8M |
TIDMAGY
RNS Number : 6554J
Allergy Therapeutics PLC
08 April 2015
For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 1. Identity of the issuer or the underlying Allergy Therapeutics Plc issuer of existing shares to which voting rights are attached: (ii) ---------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights Yes ----------------------------------------------------------------------------- ------- An acquisition or disposal of qualifying financial instruments No which may result in the acquisition of shares already issued to which voting rights are attached ----------------------------------------------------------------------------- ------- An acquisition or disposal of instruments with similar economic No effect to qualifying financial instruments ----------------------------------------------------------------------------- ------- An event changing the breakdown of voting rights No ----------------------------------------------------------------------------- ------- Other (please No specify): ------------------- -------------------------------------------------------- ------- 3. Full name of person(s) subject Invesco Limited to the notification obligation: (iii) ---------------------------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) ---------------------------------------- 5. Date of the transaction and date 31 March 2015 on which the threshold is crossed or reached: (v) ---------------------------------------- 6. Date on which issuer notified: 01 April 2015 ---------------------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 5% ---------------------------------------- 8. Notified details: A: Voting rights attached to shares (viii, ix) Class/type of Situation previous Resulting situation after the triggering shares to the triggering transaction transaction if possible using the ISIN CODE -------------------------------- ---------------------------------------------------------------------- Number Number Number Number of voting % of voting rights of of of shares rights (x) Shares Voting Rights -------------- ---------------- ------------- -------------------------- --------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ----- ------- ------ -------- ------------- ------------- ----------- -------------- ----------- GB00B02LCQ05 18,016,209 18,016,209 30,685,209 5.62% -------------- ---------------- ------------- ------------- ----------- -------------- ----------- B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration Exercise/ Number of voting % of voting instrument date (xiii) Conversion Period rights that may rights (xiv) be acquired if the instrument is exercised/ converted. --------------- ------------------------------- -------------------------- ------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) Resulting situation after the triggering transaction Type of Exercise Expiration Exercise/ Number of voting % of voting rights financial price date (xvii) Conversion rights instrument (xix, xx) instrument period refers to (xviii) ---------------- ---------------- --------------- -------------------------- ------------------------- Nominal Delta ---------------- ---------------- --------------- -------------------------- --------------- -------- Total (A+B+C) Number of voting rights Percentage of voting rights --------------------------------------------------------- 30,685,209 5.62% --------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) Invesco Asset Management Limited - 30,685,209 Proxy Voting: 10. Name of the proxy holder: Invesco Limited --------------------------- 11. Number of voting rights proxy holder will N/A cease to hold: --------------------------- 12. Date on which proxy holder will cease to N/A hold voting rights: --------------------------- 13. Additional information: 14. Contact name: Philippa Sadler -------------------------------------- 15. Contact telephone number: 01491 417 447 -------------------------------------- Note: Annex should only be submitted to the FCA not the issuer Annex: Notification of major interests in shares(xxii) A: Identity of the persons or legal entity subject to the notification obligation Full name (including legal form of legal entities) -------------------------------------- Contact address (registered office for legal entities) -------------------------------------- Phone number & email -------------------------------------- Other useful information (at least legal representative for legal persons) -------------------------------------- B: Identity of the notifier, if applicable Full name Invesco (UK) Limited -------------------------------------- Contact address Perpetual Park, Perpetual Park Drive, Henley-on-Thames. Oxon. RG9 1HH -------------------------------------- Phone number & email 01491 417 000 -------------------------------------- Other useful information Invesco (UK) Limited (e.g. functional relationship with the person or legal entity subject to the notification obligation) -------------------------------------- C: Additional information For notes on how to complete form TR-1 please see the FCA website.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUWSSRVBASRAR
1 Year Allergy Therapeutics Chart |
1 Month Allergy Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions